Pharmacodynamic studies are the prerequisites for assessing test articles. These studies not only determine the therapeutic effects of the test articles but also reveal their characteristics and potential mechanisms of action of them, supporting the proposed clinical indications and providing a reliable basis for the clinical trials. Keeping pace with industry development and market demand, InnoStar is committed to providing timely and convenient pharmacodynamic services for the research and development of new drugs. With its experienced pharmacological and pharmacodynamic research teams, InnoStar has developed a wide range of experimental models and methods for pharmacodynamic studies of new drugs at holistic, cellular, molecular and genetic levels, accelerating the progress of clients' research projects.
InnoStar is committed to providing timely and convenient pharmacodynamic services for the research and development of new drugs
InnoStar's pharmacodynamic platform boasts experienced professional technical teams, sophisticated equipment and instruments, a wide range of cell banks for various cell lines including dozens of Luc-labeled cell lines derived from a dozen of tissues and pharmacodynamic models for different diseases. The platform has built a wide range of models including orthotopic and subcutaneous implantation models, humanized mouse models, PDX models, as well as various animal models for non-tumor diseases for various product types such as small-molecule compounds, peptides, antibody reagents (monoclonal antibodies, bispecific antibodies, multi-specific antibodies, nano-antibodies, etc.), CGT products (immune cell therapy products, stem cell therapy products, oncolytic viruses, AAV vector-based gene therapy products, etc.), nucleic acids, etc.
Copyright © 2017-2021©中国·手机球探(bet007认证)官方网站-Macau App Station. All Rights Reserved. Created By VPABrand.com